Notable Labs Debt to Equity Ratio 2013-2024 | NTBLQ
Current and historical debt to equity ratio values for Notable Labs (NTBLQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Notable Labs debt/equity for the three months ending June 30, 2024 was 0.03.
| Notable Labs Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-06-30 |
$0.00B |
$0.01B |
0.53 |
| 2024-03-31 |
$0.00B |
$0.01B |
0.35 |
| 2023-12-31 |
$0.00B |
$0.02B |
0.29 |
| 2023-09-30 |
$0.00B |
$0.02B |
0.14 |
| 2023-06-30 |
$0.01B |
$0.02B |
0.28 |
| 2023-03-31 |
$0.01B |
$0.02B |
0.41 |
| 2022-12-31 |
$0.04B |
$-0.04B |
-1.15 |
| 2022-09-30 |
$0.01B |
$0.03B |
0.40 |
| 2022-06-30 |
$0.01B |
$0.03B |
0.32 |
| 2022-03-31 |
$0.01B |
$0.04B |
0.32 |
| 2021-12-31 |
$0.01B |
$0.05B |
0.28 |
| 2021-09-30 |
$0.01B |
$0.05B |
0.24 |
| 2021-06-30 |
$0.01B |
$0.05B |
0.24 |
| 2021-03-31 |
$0.01B |
$0.04B |
0.32 |
| 2020-12-31 |
$0.01B |
$0.03B |
0.35 |
| 2020-09-30 |
$0.01B |
$0.04B |
0.29 |
| 2020-06-30 |
$0.01B |
$0.04B |
0.24 |
| 2020-03-31 |
$0.01B |
$0.03B |
0.37 |
| 2019-12-31 |
$0.01B |
$0.04B |
0.36 |
| 2019-09-30 |
$0.01B |
$0.04B |
0.29 |
| 2019-06-30 |
$0.01B |
$0.05B |
0.26 |
| 2019-03-31 |
$0.01B |
$0.05B |
0.22 |
| 2018-12-31 |
$0.01B |
$0.05B |
0.14 |
| 2018-09-30 |
$0.01B |
$0.06B |
0.13 |
| 2018-06-30 |
$0.01B |
$0.06B |
0.14 |
| 2018-03-31 |
$0.01B |
$0.05B |
0.20 |
| 2017-12-31 |
$0.01B |
$0.06B |
0.18 |
| 2017-09-30 |
$0.01B |
$0.03B |
0.17 |
| 2017-06-30 |
$0.01B |
$0.04B |
0.17 |
| 2017-03-31 |
$0.01B |
$0.04B |
0.12 |
| 2016-12-31 |
$0.01B |
$0.04B |
0.12 |
| 2016-09-30 |
$0.00B |
$0.05B |
0.08 |
| 2016-06-30 |
$0.00B |
$0.05B |
0.09 |
| 2016-03-31 |
$0.00B |
$0.03B |
0.13 |
| 2015-12-31 |
$0.00B |
$0.04B |
0.12 |
| 2015-09-30 |
$0.01B |
$0.02B |
0.22 |
| 2015-06-30 |
$0.00B |
$0.03B |
0.12 |
| 2015-03-31 |
$0.00B |
$0.03B |
0.09 |
| 2014-12-31 |
$0.00B |
$0.04B |
0.09 |
| 2014-09-30 |
$0.01B |
$0.00B |
1.87 |
| 2014-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2014-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2013-12-31 |
$0.04B |
$-0.02B |
-1.50 |
| 2013-09-30 |
$0.00B |
|
0.00 |
| 2012-12-31 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
